John A. Lewicki, EVP & Chief Scientific Officer at OncoMed Pharmaceuticals Inc (OMED), sold 2,162 shares at $21.33 ($48K) on 2016-01-07, disclosed to the SEC on 2016-01-08.
Open-market sale of $48k OMED by EVP & Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.56 | 69 | $1K | 3.1% |
| 2 | $22.30 | 2,092 | $47K | 96.9% |
| 3 | $21.33 | 1 | $21 | 0.0% |
| Total | $22.28 avg | 2,162 | $48K | 100% |
| Filing → |
| OMED | SELL | 2018-10-11 | $2K | — | Filing → |
| OMED | SELL | 2018-10-10 | $5K | — | Filing → |
| OMED | SELL | 2018-04-26 | $12K | — | Filing → |